Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ashley Edward Fenwick is active.

Publication


Featured researches published by Ashley Edward Fenwick.


Bioorganic & Medicinal Chemistry Letters | 2012

SAR and biological evaluation of 3-azabicyclo[3.1.0]hexane derivatives as μ opioid ligands.

Graham Lunn; Lee R. Roberts; Douglas James Critcher; Sara Douglas; Ashley Edward Fenwick; David Morris Gethin; Graham Goodwin; David H.J. Greenway; Sean D.W. Greenwood; Kim Thomas Hall; Martin Thomas; Stephen Thompson; David H. Williams; Gavin Wood; Andrew Wylie

3-Azabicyclo[3.1.0]hexane compounds were designed as novel achiral μ opioid receptor ligands for the treatment of pruritus in dogs. In this paper, we describe the SAR of this class of opioid ligand, highlighting changes to the lead structure which led to compounds having picomolar binding affinity, selective for the μ receptor over δ and κ subtypes. Some subtleties of functional activity will also be described.


Archive | 2001

3-AZABICYCLO (3.1.0) HEXANE DERIVATIVES HAVING OPIOID RECEPTOR AFFINITY

Bernard Joseph Banks; Douglas James Critcher; Ashley Edward Fenwick; David Morris Gethin; Stephen Paul Gibson; Graham Lunn


Archive | 2007

HETEROCYCLIC COMPOUNDS USEFUL AS ANABOLIC AGENTS FOR LIVESTOCK ANIMALS

Jessica Boyle; Ashley Edward Fenwick; David Morris Gethin; Catherine Frances Mccusker


Archive | 2011

Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors

Timothy Allen Johnson; Ashley Edward Fenwick; Graham M. Kyne


Archive | 2014

PYRROLO [2, 3 -D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF JANUS- RELATED KINASES (JAK)

Matthew Frank Brown; Ashley Edward Fenwick; Mark Edward Flanagan; Andrea J. Gonzales; Timothy Allan Johnson; Neelu Kaila; Mark J. Mitton-Fry; Joseph Walter Strohbach; Ruth E. Tenbrink; John David Trzupek; Rayomand Jal Unwalla; Michael L. Vazquez; Mihir D. Parikh


Archive | 2015

Pyrrolo[2,3-D]pyrimidine derivatives

Matthew Frank Brown; Ashley Edward Fenwick; Mark Edward Flanagan; Andrea J. Gonzales; Timothy Allan Johnson; Neelu Kaila; Mark J. Mitton-Fry; Joseph Walter Strohbach; Ruth E. Tenbrink; John David Trzupek; Rayomand Jal Unwalla; Michael L. Vazquez; Mihir D. Parikh


Archive | 2017

PYRROLO [2, 3 -D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF JANUS KINASES (JAK)

Matthew Frank Brown; Ashley Edward Fenwick; Mark Edward Flanagan; Andrea J. Gonzales; Timothy Allan Johnson; Neelu Kaila; Mark J. Mitton-Fry; Joseph Walter Strohbach; Ruth E. Tenbrink; John David Trzupek; Rayomand Jal Unwalla; Michael L. Vazquez; Mihir D. Parikh


Archive | 2014

Dérivés de pyrrolo[2,3-d]pyrimidine en tant qu'inhibiteurs de janus kinases (jak)

Matthew Frank Brown; Ashley Edward Fenwick; Mark Edward Flanagan; Andrea J. Gonzales; Timothy Allan Johnson; Neelu Kaila; Mark J. Mitton-Fry; Joseph Walter Strohbach; Ruth E. Tenbrink; John David Trzupek; Rayomand Jal Unwalla; Michael L. Vazquez


Archive | 2011

Composés d'urée à base de pyrrolo[2,3-d]pyrimidine à titre d'inhibiteurs de jak

Timothy Allen Johnson; Ashley Edward Fenwick; Graham M. Kyne


Archive | 2007

Als anabole mittel für vieh geeignete heterozyklische verbindungen As anabolic agent for cattle suitable heterocyclic compounds

Jessica Boyle; Ashley Edward Fenwick; David Morris Gethin; Catherine Frances Mccusker

Researchain Logo
Decentralizing Knowledge